Escalating tensions between the White House and the Federal Reserve – whereby an investigation of Powell over his testimony about the central bank’s building renovation project was met with a stern rebuke by the Fed Chair alleging that political motivations are driving the Executive branch in strong-arming the central bank to ease policy – hit sentiment to start the new week, though U.S. indices recovered midday to finish slightly higher. Walmart’s (WMT) record highs helped Consumer Staples to the top of the S&P 500 sectors in today’s performance, while Energy and Financials were the worst performers and finished in the red. In the opening hour of the evening trade, index futures are modestly lower – S&P e-minis, Dow Industrials, and Nasdaq 100 are all down by about 0.1%.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Macro currents are dominating market narratives, and tomorrow’s CPI report will give the Fed more input on the direction of policy to start 2026. In commodities, precious metals saw fresh record highs on Monday, though both Silver and Gold are down somewhat in the evening session, weighed down by renewed bullish momentum for U.S. Dollar. Q4 earnings season also kicks off on Tuesday, with JPMorgan (JPM) and Delta Airlines (DAL) on tap to report results.
Check out this evening’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Revvity (RVTY) up 8.8% after Q4 pre-announcement
- Option Care Health (OPCH) up 3.3% after FY25 guidance
- Wayfair (W) up 1.5% after partnering with Google on AI-powered shopping
- Kennametal (KMT) up 1.1% after being upgraded at Jefferies
- NETSTREIT (NTST) up 0.9% after FY26 guidance
LOWER –
- Saia (SAIA) down 1.9% after being cut to In Line at Evercore ISI
- BioMarin Pharmaceutical (BMRN) down 0.7% after naming Arpit Dave as Chief Digital and Information Officer
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
- Revvity sees FY25 EPS exceeding upper end of prior view of $4.90-$5.00
- Revvity sees Q4 revenue of about $772M, consensus $728.1M
- Revvity up 1% at $105 following Q4 revenue pre-announcement
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 11
- Revvity announces collaboration with Eli Lilly on AI drug discovery models